Novasep and instrAction expand alliance to include taxane purification

Companies will develop solutions to change manufacturing paradigm for new and generic anti-cancer compounds

15-Feb-2011 - France

Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced they have expanded their worldwide strategic alliance to include the purification of taxanes, a well-known class of anti-cancer compounds.

This extended collaboration enables Novasep to develop and operate or supply optimized large-scale chromatography processes for cost-effective purification of taxane-based active pharmaceutical ingredients (APIs) and intermediates. The two companies announced a strategic alliance covering non-chiral chromatography in July 2010. The extended relationship means Novasep adds enhanced taxane anti-cancer compound capabilities to its extensive range of manufacturing solutions for life science industries.

Other news from the department business & finance

These products might interest you

Pharmaceutical Substances

Pharmaceutical Substances by Thieme Verlag

Look up Industrial Syntheses of 2,600 APIs

Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

technical literature
KNAUER IJM NanoScaler

KNAUER IJM NanoScaler by KNAUER

Efficient formulation of lipid nanoparticles for RNA-based therapies

Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input

formulation systems
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance